MYGN240517P00017000 Option on Myriad Genetics
| MYGN Stock | USD 25.32 0.71 2.89% |
Myriad Genetics' option chain provides insight into all available option contracts written on Myriad Genetics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Myriad Genetics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Myriad option contract.
In The Money vs. Out of Money Option Contracts on Myriad Genetics
Analyzing Myriad Genetics' in-the-money options over time can help investors to take a profitable long position in Myriad Genetics regardless of its overall volatility. This is especially true when Myriad Genetics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Myriad Genetics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Myriad Genetics' stock while costing only a fraction of its price.
Myriad Genetics' latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 280.54 with a put-to-call open interest ratio of 0.67 over 64 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 1, with calls trading at the volume of 20. This yields a 0.05 put-to-call volume ratio. The Myriad Genetics option chain provides detailed quote and price information for the current Myriad Genetics option contracts. It shows all of Myriad Genetics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
Myriad Genetics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Myriad Genetics' lending market. For example, when Myriad Genetics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Myriad Genetics, he or she must hedge the risk by shorting Myriad Genetics stock over its option's life.
2024-05-17
The chart above shows Myriad Genetics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Myriad Genetics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Myriad Genetics' option, there is no secondary market available for investors to trade.
Myriad Genetics' stock options are financial instruments that give investors the right to buy or sell shares of Myriad Genetics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Myriad stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Myriad Genetics' stock price goes up or down, the stock options follow.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myriad Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Please note that buying 'in-the-money' options on Myriad Genetics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Myriad Genetics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Myriad Genetics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Myriad Stock moves the wrong way.
At this time, Myriad Genetics' Liabilities And Stockholders Equity is very stable compared to the past year. As of the 17th of May 2024, Other Stockholder Equity is likely to grow to about 1.5 B, while Total Stockholder Equity is likely to drop about 541.5 M. Myriad Current Options Market Mood
Myriad Genetics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Myriad Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Myriad Genetics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Myriad Genetics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Myriad Genetics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Myriad contract
Base on the Rule 16, the options market is currently suggesting that Myriad Genetics will have an average daily up or down price movement of about 17.53% per day over the life of the 2024-05-17 option contract. With Myriad Genetics trading at USD 25.32, that is roughly USD 4.44. If you think that the market is fully incorporating Myriad Genetics' daily price movement you should consider buying Myriad Genetics options at the current volatility level of 280.54%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Myriad |
Purchasing Myriad Genetics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Myriad calls. Remember, the seller must deliver Myriad Genetics stock to the call owner when a call is exercised.
Myriad Genetics Option Chain
When Myriad Genetics' strike price is surpassing the current stock price, the option contract against Myriad Genetics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Myriad Genetics' option chain is a display of a range of information that helps investors for ways to trade options on Myriad. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Myriad. It also shows strike prices and maturity days for a Myriad Genetics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $11.0 | 0.9241 | 0.0076 | 0 | 2024-05-17 | 13.4 - 15.6 | 0.0 | In |
Call | 2024-05-17 CALL at $12.0 | 0.9158 | 0.009 | 0 | 2024-05-17 | 12.4 - 14.6 | 0.0 | In |
Call | 2024-05-17 CALL at $13.0 | 0.9423 | 0.0098 | 0 | 2024-05-17 | 10.3 - 13.6 | 0.0 | In |
Call | 2024-05-17 CALL at $14.0 | 0.8971 | 0.0126 | 0 | 2024-05-17 | 10.4 - 12.6 | 0.0 | In |
Call | 2024-05-17 CALL at $15.0 | 0.8863 | 0.015 | 1 | 2024-05-17 | 9.4 - 11.6 | 5.0 | In |
Call | 2024-05-17 CALL at $16.0 | 0.8743 | 0.0178 | 22 | 2024-05-17 | 8.4 - 10.6 | 4.9 | In |
Call | 2024-05-17 CALL at $17.0 | 0.8606 | 0.0213 | 10 | 2024-05-17 | 7.4 - 9.6 | 5.0 | In |
Call | 2024-05-17 CALL at $18.0 | 0.8448 | 0.0256 | 13 | 2024-05-17 | 6.4 - 8.6 | 1.9 | In |
Call | 2024-05-17 CALL at $19.0 | 0.8263 | 0.0312 | 35 | 2024-05-17 | 5.4 - 7.6 | 6.0 | In |
Call | 2024-05-17 CALL at $20.0 | 0.8705 | 0.0426 | 31 | 2024-05-17 | 3.3 - 6.6 | 2.25 | In |
Call | 2024-05-17 CALL at $21.0 | 0.7281 | 0.0357 | 100 | 2024-05-17 | 3.4 - 5.5 | 3.5 | In |
Call | 2024-05-17 CALL at $22.0 | 0.7411 | 0.0642 | 1035 | 2024-05-17 | 2.45 - 4.5 | 0.95 | In |
Call | 2024-05-17 CALL at $24.0 | 0.8487 | 0.3934 | 422 | 2024-05-17 | 0.4 - 0.9 | 0.35 | In |
Put | 2024-05-17 PUT at $22.0 | -0.1241 | 0.0823 | 45 | 2024-05-17 | 0.0 - 0.1 | 0.16 | Out |
Put | 2024-05-17 PUT at $27.0 | -0.601 | 0.0638 | 0 | 2024-05-17 | 0.6 - 3.9 | 0.0 | In |
Put | 2024-05-17 PUT at $28.0 | -0.8564 | 0.0796 | 0 | 2024-05-17 | 3.2 - 3.6 | 0.0 | In |
Put | 2024-05-17 PUT at $29.0 | -0.825 | 0.0645 | 0 | 2024-05-17 | 3.2 - 6.3 | 0.0 | In |
Put | 2024-05-17 PUT at $30.0 | -0.8536 | 0.0534 | 0 | 2024-05-17 | 5.1 - 5.7 | 0.0 | In |
Put | 2024-05-17 PUT at $31.0 | -0.8947 | 0.0427 | 0 | 2024-05-17 | 6.2 - 6.6 | 0.0 | In |
Put | 2024-05-17 PUT at $32.0 | -0.902 | 0.037 | 0 | 2024-05-17 | 7.2 - 7.6 | 0.0 | In |
Put | 2024-05-17 PUT at $33.0 | -0.8569 | 0.0371 | 0 | 2024-05-17 | 8.1 - 9.5 | 0.0 | In |
Put | 2024-05-17 PUT at $34.0 | -0.8636 | 0.0337 | 0 | 2024-05-17 | 9.2 - 10.4 | 0.0 | In |
Put | 2024-05-17 PUT at $35.0 | -0.9487 | 0.0209 | 0 | 2024-05-17 | 10.2 - 10.8 | 0.0 | In |
Put | 2024-05-17 PUT at $36.0 | -0.9346 | 0.022 | 0 | 2024-05-17 | 10.6 - 12.5 | 0.0 | In |
Put | 2024-05-17 PUT at $37.0 | -0.8208 | 0.0287 | 0 | 2024-05-17 | 12.1 - 14.2 | 0.0 | In |
Myriad Genetics Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Myriad Genetics Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Myriad Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Myriad Genetics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Myriad Genetics Corporate Management
Elected by the shareholders, the Myriad Genetics' board of directors comprises two types of representatives: Myriad Genetics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Myriad. The board's role is to monitor Myriad Genetics' management team and ensure that shareholders' interests are well served. Myriad Genetics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Myriad Genetics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nicole Lambert | Chief Officer | Profile | |
| Clivetty Martinez | Chief Officer | Profile | |
| Pamela Wong | Chief Officer | Profile | |
| Shereen Solaiman | Chief Officer | Profile |
Already Invested in Myriad Genetics?
The danger of trading Myriad Genetics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Myriad Genetics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Myriad Genetics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Myriad Genetics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Myriad Genetics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myriad Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myriad Genetics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myriad Genetics Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myriad Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.Note that the Myriad Genetics information on this page should be used as a complementary analysis to other Myriad Genetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Myriad Stock analysis
When running Myriad Genetics' price analysis, check to measure Myriad Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myriad Genetics is operating at the current time. Most of Myriad Genetics' value examination focuses on studying past and present price action to predict the probability of Myriad Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Myriad Genetics' price. Additionally, you may evaluate how the addition of Myriad Genetics to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Myriad Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.80) | Revenue Per Share 9.114 | Quarterly Revenue Growth 0.116 | Return On Assets (0.07) | Return On Equity (0.29) |
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.